Home Healthcare IT Viral Vector Manufacturing Market

Viral Vector Manufacturing Market Size, Share & Trends Analysis Report By Type (Viral Vectors, Plasmid DNA), By Workflow (Upstream Manufacturing, Downstream Manufacturing), By Application (Gene Therapy, Vaccinology), By Disease (Cancer, Genetic Disorders, Infectious Diseases), By End User (Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format: | Report Code: SRHI300DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Regulatory Framework
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  7. ESG Trends
  8. Global Viral Vector Manufacturing Market Size Analysis
    1. Global Viral Vector Manufacturing Market Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Viral Vectors
        1. By Value
        2. Retroviruses
          1. Retroviruses By Value
        3. Adenoviruses
          1. Adenoviruses By Value
        4. Adeno-associated viruses (AAVs)
          1. Adeno-associated viruses (AAVs) By Value
        5. Lentiviruses
          1. Lentiviruses By Value
        6. Others
          1. Others By Value
      3. Plasmid DNA
        1. By Value
    3. By Workflow
      1. Introduction
        1. Workflow By Value
      2. Upstream Manufacturing
        1. By Value
        2. Vector Amplification, Editing and Expansion
          1. Vector Amplification, Editing and Expansion By Value
        3. Vector Recovery/Harvesting
          1. Vector Recovery/Harvesting By Value
      3. Downstream Manufacturing
        1. By Value
        2. Purification
          1. Purification By Value
        3. Fill Finish
          1. Fill Finish By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Gene Therapy
        1. By Value
      3. Vaccinology
        1. By Value
    5. By Disease
      1. Introduction
        1. Disease By Value
      2. Cancer
        1. By Value
      3. Genetic Disorders
        1. By Value
      4. Infectious Diseases
        1. By Value
    6. By End User
      1. Introduction
        1. End User By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Academics and Research Institutes
        1. By Value
      4. Others
        1. By Value
  9. North America Market Analysis
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Viral Vectors
        1. By Value
        2. Retroviruses
          1. Retroviruses By Value
        3. Adenoviruses
          1. Adenoviruses By Value
        4. Adeno-associated viruses (AAVs)
          1. Adeno-associated viruses (AAVs) By Value
        5. Lentiviruses
          1. Lentiviruses By Value
        6. Others
          1. Others By Value
      3. Plasmid DNA
        1. By Value
    3. By Workflow
      1. Introduction
        1. Workflow By Value
      2. Upstream Manufacturing
        1. By Value
        2. Vector Amplification, Editing and Expansion
          1. Vector Amplification, Editing and Expansion By Value
        3. Vector Recovery/Harvesting
          1. Vector Recovery/Harvesting By Value
      3. Downstream Manufacturing
        1. By Value
        2. Purification
          1. Purification By Value
        3. Fill Finish
          1. Fill Finish By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Gene Therapy
        1. By Value
      3. Vaccinology
        1. By Value
    5. By Disease
      1. Introduction
        1. Disease By Value
      2. Cancer
        1. By Value
      3. Genetic Disorders
        1. By Value
      4. Infectious Diseases
        1. By Value
    6. By End User
      1. Introduction
        1. End User By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Academics and Research Institutes
        1. By Value
      4. Others
        1. By Value
    7. U.S.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Viral Vectors
          1. By Value
          2. Retroviruses
            1. Retroviruses By Value
          3. Adenoviruses
            1. Adenoviruses By Value
          4. Adeno-associated viruses (AAVs)
            1. Adeno-associated viruses (AAVs) By Value
          5. Lentiviruses
            1. Lentiviruses By Value
          6. Others
            1. Others By Value
        3. Plasmid DNA
          1. By Value
      2. By Workflow
        1. Introduction
          1. Workflow By Value
        2. Upstream Manufacturing
          1. By Value
          2. Vector Amplification, Editing and Expansion
            1. Vector Amplification, Editing and Expansion By Value
          3. Vector Recovery/Harvesting
            1. Vector Recovery/Harvesting By Value
        3. Downstream Manufacturing
          1. By Value
          2. Purification
            1. Purification By Value
          3. Fill Finish
            1. Fill Finish By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Gene Therapy
          1. By Value
        3. Vaccinology
          1. By Value
      4. By Disease
        1. Introduction
          1. Disease By Value
        2. Cancer
          1. By Value
        3. Genetic Disorders
          1. By Value
        4. Infectious Diseases
          1. By Value
      5. By End User
        1. Introduction
          1. End User By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Academics and Research Institutes
          1. By Value
        4. Others
          1. By Value
    8. Canada
  10. Europe Market Analysis
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Viral Vectors
        1. By Value
        2. Retroviruses
          1. Retroviruses By Value
        3. Adenoviruses
          1. Adenoviruses By Value
        4. Adeno-associated viruses (AAVs)
          1. Adeno-associated viruses (AAVs) By Value
        5. Lentiviruses
          1. Lentiviruses By Value
        6. Others
          1. Others By Value
      3. Plasmid DNA
        1. By Value
    3. By Workflow
      1. Introduction
        1. Workflow By Value
      2. Upstream Manufacturing
        1. By Value
        2. Vector Amplification, Editing and Expansion
          1. Vector Amplification, Editing and Expansion By Value
        3. Vector Recovery/Harvesting
          1. Vector Recovery/Harvesting By Value
      3. Downstream Manufacturing
        1. By Value
        2. Purification
          1. Purification By Value
        3. Fill Finish
          1. Fill Finish By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Gene Therapy
        1. By Value
      3. Vaccinology
        1. By Value
    5. By Disease
      1. Introduction
        1. Disease By Value
      2. Cancer
        1. By Value
      3. Genetic Disorders
        1. By Value
      4. Infectious Diseases
        1. By Value
    6. By End User
      1. Introduction
        1. End User By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Academics and Research Institutes
        1. By Value
      4. Others
        1. By Value
    7. U.K.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Viral Vectors
          1. By Value
          2. Retroviruses
            1. Retroviruses By Value
          3. Adenoviruses
            1. Adenoviruses By Value
          4. Adeno-associated viruses (AAVs)
            1. Adeno-associated viruses (AAVs) By Value
          5. Lentiviruses
            1. Lentiviruses By Value
          6. Others
            1. Others By Value
        3. Plasmid DNA
          1. By Value
      2. By Workflow
        1. Introduction
          1. Workflow By Value
        2. Upstream Manufacturing
          1. By Value
          2. Vector Amplification, Editing and Expansion
            1. Vector Amplification, Editing and Expansion By Value
          3. Vector Recovery/Harvesting
            1. Vector Recovery/Harvesting By Value
        3. Downstream Manufacturing
          1. By Value
          2. Purification
            1. Purification By Value
          3. Fill Finish
            1. Fill Finish By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Gene Therapy
          1. By Value
        3. Vaccinology
          1. By Value
      4. By Disease
        1. Introduction
          1. Disease By Value
        2. Cancer
          1. By Value
        3. Genetic Disorders
          1. By Value
        4. Infectious Diseases
          1. By Value
      5. By End User
        1. Introduction
          1. End User By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Academics and Research Institutes
          1. By Value
        4. Others
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
  11. APAC Market Analysis
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Viral Vectors
        1. By Value
        2. Retroviruses
          1. Retroviruses By Value
        3. Adenoviruses
          1. Adenoviruses By Value
        4. Adeno-associated viruses (AAVs)
          1. Adeno-associated viruses (AAVs) By Value
        5. Lentiviruses
          1. Lentiviruses By Value
        6. Others
          1. Others By Value
      3. Plasmid DNA
        1. By Value
    3. By Workflow
      1. Introduction
        1. Workflow By Value
      2. Upstream Manufacturing
        1. By Value
        2. Vector Amplification, Editing and Expansion
          1. Vector Amplification, Editing and Expansion By Value
        3. Vector Recovery/Harvesting
          1. Vector Recovery/Harvesting By Value
      3. Downstream Manufacturing
        1. By Value
        2. Purification
          1. Purification By Value
        3. Fill Finish
          1. Fill Finish By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Gene Therapy
        1. By Value
      3. Vaccinology
        1. By Value
    5. By Disease
      1. Introduction
        1. Disease By Value
      2. Cancer
        1. By Value
      3. Genetic Disorders
        1. By Value
      4. Infectious Diseases
        1. By Value
    6. By End User
      1. Introduction
        1. End User By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Academics and Research Institutes
        1. By Value
      4. Others
        1. By Value
    7. China
      1. By Type
        1. Introduction
          1. Type By Value
        2. Viral Vectors
          1. By Value
          2. Retroviruses
            1. Retroviruses By Value
          3. Adenoviruses
            1. Adenoviruses By Value
          4. Adeno-associated viruses (AAVs)
            1. Adeno-associated viruses (AAVs) By Value
          5. Lentiviruses
            1. Lentiviruses By Value
          6. Others
            1. Others By Value
        3. Plasmid DNA
          1. By Value
      2. By Workflow
        1. Introduction
          1. Workflow By Value
        2. Upstream Manufacturing
          1. By Value
          2. Vector Amplification, Editing and Expansion
            1. Vector Amplification, Editing and Expansion By Value
          3. Vector Recovery/Harvesting
            1. Vector Recovery/Harvesting By Value
        3. Downstream Manufacturing
          1. By Value
          2. Purification
            1. Purification By Value
          3. Fill Finish
            1. Fill Finish By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Gene Therapy
          1. By Value
        3. Vaccinology
          1. By Value
      4. By Disease
        1. Introduction
          1. Disease By Value
        2. Cancer
          1. By Value
        3. Genetic Disorders
          1. By Value
        4. Infectious Diseases
          1. By Value
      5. By End User
        1. Introduction
          1. End User By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Academics and Research Institutes
          1. By Value
        4. Others
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
  12. Middle East and Africa Market Analysis
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Viral Vectors
        1. By Value
        2. Retroviruses
          1. Retroviruses By Value
        3. Adenoviruses
          1. Adenoviruses By Value
        4. Adeno-associated viruses (AAVs)
          1. Adeno-associated viruses (AAVs) By Value
        5. Lentiviruses
          1. Lentiviruses By Value
        6. Others
          1. Others By Value
      3. Plasmid DNA
        1. By Value
    3. By Workflow
      1. Introduction
        1. Workflow By Value
      2. Upstream Manufacturing
        1. By Value
        2. Vector Amplification, Editing and Expansion
          1. Vector Amplification, Editing and Expansion By Value
        3. Vector Recovery/Harvesting
          1. Vector Recovery/Harvesting By Value
      3. Downstream Manufacturing
        1. By Value
        2. Purification
          1. Purification By Value
        3. Fill Finish
          1. Fill Finish By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Gene Therapy
        1. By Value
      3. Vaccinology
        1. By Value
    5. By Disease
      1. Introduction
        1. Disease By Value
      2. Cancer
        1. By Value
      3. Genetic Disorders
        1. By Value
      4. Infectious Diseases
        1. By Value
    6. By End User
      1. Introduction
        1. End User By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Academics and Research Institutes
        1. By Value
      4. Others
        1. By Value
    7. UAE
      1. By Type
        1. Introduction
          1. Type By Value
        2. Viral Vectors
          1. By Value
          2. Retroviruses
            1. Retroviruses By Value
          3. Adenoviruses
            1. Adenoviruses By Value
          4. Adeno-associated viruses (AAVs)
            1. Adeno-associated viruses (AAVs) By Value
          5. Lentiviruses
            1. Lentiviruses By Value
          6. Others
            1. Others By Value
        3. Plasmid DNA
          1. By Value
      2. By Workflow
        1. Introduction
          1. Workflow By Value
        2. Upstream Manufacturing
          1. By Value
          2. Vector Amplification, Editing and Expansion
            1. Vector Amplification, Editing and Expansion By Value
          3. Vector Recovery/Harvesting
            1. Vector Recovery/Harvesting By Value
        3. Downstream Manufacturing
          1. By Value
          2. Purification
            1. Purification By Value
          3. Fill Finish
            1. Fill Finish By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Gene Therapy
          1. By Value
        3. Vaccinology
          1. By Value
      4. By Disease
        1. Introduction
          1. Disease By Value
        2. Cancer
          1. By Value
        3. Genetic Disorders
          1. By Value
        4. Infectious Diseases
          1. By Value
      5. By End User
        1. Introduction
          1. End User By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Academics and Research Institutes
          1. By Value
        4. Others
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
  13. LATAM Market Analysis
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Viral Vectors
        1. By Value
        2. Retroviruses
          1. Retroviruses By Value
        3. Adenoviruses
          1. Adenoviruses By Value
        4. Adeno-associated viruses (AAVs)
          1. Adeno-associated viruses (AAVs) By Value
        5. Lentiviruses
          1. Lentiviruses By Value
        6. Others
          1. Others By Value
      3. Plasmid DNA
        1. By Value
    3. By Workflow
      1. Introduction
        1. Workflow By Value
      2. Upstream Manufacturing
        1. By Value
        2. Vector Amplification, Editing and Expansion
          1. Vector Amplification, Editing and Expansion By Value
        3. Vector Recovery/Harvesting
          1. Vector Recovery/Harvesting By Value
      3. Downstream Manufacturing
        1. By Value
        2. Purification
          1. Purification By Value
        3. Fill Finish
          1. Fill Finish By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Gene Therapy
        1. By Value
      3. Vaccinology
        1. By Value
    5. By Disease
      1. Introduction
        1. Disease By Value
      2. Cancer
        1. By Value
      3. Genetic Disorders
        1. By Value
      4. Infectious Diseases
        1. By Value
    6. By End User
      1. Introduction
        1. End User By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Academics and Research Institutes
        1. By Value
      4. Others
        1. By Value
    7. Brazil
      1. By Type
        1. Introduction
          1. Type By Value
        2. Viral Vectors
          1. By Value
          2. Retroviruses
            1. Retroviruses By Value
          3. Adenoviruses
            1. Adenoviruses By Value
          4. Adeno-associated viruses (AAVs)
            1. Adeno-associated viruses (AAVs) By Value
          5. Lentiviruses
            1. Lentiviruses By Value
          6. Others
            1. Others By Value
        3. Plasmid DNA
          1. By Value
      2. By Workflow
        1. Introduction
          1. Workflow By Value
        2. Upstream Manufacturing
          1. By Value
          2. Vector Amplification, Editing and Expansion
            1. Vector Amplification, Editing and Expansion By Value
          3. Vector Recovery/Harvesting
            1. Vector Recovery/Harvesting By Value
        3. Downstream Manufacturing
          1. By Value
          2. Purification
            1. Purification By Value
          3. Fill Finish
            1. Fill Finish By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Gene Therapy
          1. By Value
        3. Vaccinology
          1. By Value
      4. By Disease
        1. Introduction
          1. Disease By Value
        2. Cancer
          1. By Value
        3. Genetic Disorders
          1. By Value
        4. Infectious Diseases
          1. By Value
      5. By End User
        1. Introduction
          1. End User By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Academics and Research Institutes
          1. By Value
        4. Others
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
  14. Competitive Landscape
    1. Viral Vector Manufacturing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
  15. Market Players Assessment
    1. Merck GA
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Lonza
    3. BD
    4. Fujifilm Diosynth biotechnologies USA Inc.
    5. Brammer Bio
    6. Cell Therapy Catapult Limited
    7. Waisman Biomanufacturing
    8. GENEZEN LABORATORIES
    9. Yposkesi Inc.
    10. REGENXBIO Inc.
  16. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  17. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  18. Disclaimer
Get This Report

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.